About Biosion
Biosion is a company based in Nanjing (China) founded in 2017 by Mingjiu Chen.. Biosion has raised $76.44 million across 4 funding rounds from investors including HMC Ventures, GF Xinde Investment Management and Fangyi Equity Investment Fund. Biosion operates in a competitive market with competitors including Actelion, Sana Biotechnology, Janux Therapeutics, GigaGen and ASLAN Pharmaceuticals, among others.
- Headquarter Nanjing, China
- Founders Mingjiu Chen
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$76.44 M (USD)
in 4 rounds
-
Latest Funding Round
-
Investors
HMC Ventures
& 8 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Unlock access to complete
Funding Insights of Biosion
Biosion has successfully raised a total of $76.44M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Last Round
-
First Round
First Round
(18 Dec 2020)
- Investors Count 9
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2023 | Amount | Series B - Biosion | Valuation | HMC Ventures |
|
| Dec, 2022 | Amount | Series B - Biosion | Valuation | GF Xinde Investment Management | |
| Dec, 2021 | Amount | Series B - Biosion | Valuation | 3E BioVentures |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Biosion
Biosion has secured backing from 9 investors, including venture fund investors. Prominent investors backing the company include HMC Ventures, GF Xinde Investment Management and Fangyi Equity Investment Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Biosion
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Biosion
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Biosion Comparisons
Competitors of Biosion
Biosion operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Actelion, Sana Biotechnology, Janux Therapeutics, GigaGen and ASLAN Pharmaceuticals, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Innovative treatments for orphan diseases are discovered, developed, and commercialized.
|
|
| domain | founded_year | HQ Location |
Genetically engineered cell therapies are developed for multiple disorders.
|
|
| domain | founded_year | HQ Location |
Immunotherapeutics for cancer treatment are developed to target solid tumors.
|
|
| domain | founded_year | HQ Location |
T-cell and antibody-based therapeutics are developed via single-cell sequencing platforms.
|
|
| domain | founded_year | HQ Location |
Targeted small molecules are developed for oncology treatments.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Biosion
Frequently Asked Questions about Biosion
When was Biosion founded?
Biosion was founded in 2017 and raised its 1st funding round 3 years after it was founded.
Where is Biosion located?
Biosion is headquartered in Nanjing, China. It is registered at Nanjing, Jiangsu, China.
Who is the current CEO of Biosion?
Mingjiu Chen is the current CEO of Biosion. They have also founded this company.
Is Biosion a funded company?
Biosion is a funded company, having raised a total of $76.44M across 4 funding rounds to date. The company's 1st funding round was a Series B of $31.49M, raised on Dec 18, 2020.
What does Biosion do?
Biosion was founded in 2017 and is headquartered in Nanjing, China. Antibody-based therapeutics are developed by the company to address diseases such as asthma, atopic dermatitis, chronic obstructive pulmonary disease, solid cancers, and blood cancers. Drug candidates including BSI 045A, which targets IL4R, and BSI 045B for respiratory conditions are advanced. Additionally, BSI 038 is targeted at CD40 for oncology applications. Operations focus on immunotherapy innovations in the biotechnology sector.
Who are the top competitors of Biosion?
Biosion's top competitors include Janux Therapeutics, Kronos Bio and Sana Biotechnology.
Who are Biosion's investors?
Biosion has 9 investors. Key investors include HMC Ventures, GF Xinde Investment Management, Fangyi Equity Investment Fund, Addor Capital, and Suxin Venture Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.